Medicine and Dentistry
Patient
100%
Therapeutic Procedure
62%
Nodular Melanoma
56%
Combination Therapy
39%
Inpatient
35%
Ganglioglioma
34%
Diseases
28%
Overall Survival
26%
Brain
26%
Metastatic Melanoma
25%
Neoplasm
25%
Survival
25%
Malignant Neoplasm
25%
Immunotherapy
25%
Organ
23%
Clinical Trial
22%
Hospital
22%
Quality of Life
21%
Primary Tumor
18%
Isocitrate Dehydrogenase
18%
Chemotherapeutic Agent
18%
Drug
18%
Cancer Therapy
18%
Proton
18%
Glioblastoma
18%
Seasonal Variation
18%
Personalized Medicine
18%
Mental Health
18%
Oligoastrocytoma
18%
Selinexor
18%
Photon Therapy
18%
Diagnostics
18%
Cancer Staging
18%
Female Genital Tract Cancer
18%
Metastatic Carcinoma
16%
Surgery
14%
Targeted Therapy
14%
Hippocampus
11%
Person
11%
Radiation Therapy
11%
Relative Biologic Effectiveness
11%
Diagnosis
11%
Follow up
10%
Health
9%
Brainstem
9%
Spinal Cord
9%
Brain Tumor
9%
Neuro-Oncology
9%
Proportional Hazards Model
7%
Next Generation Sequencing
7%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
56%
Metastatic Melanoma
44%
Diseases
34%
Malignant Neoplasm
29%
Overall Survival
28%
Immunotherapy
27%
Nivolumab
20%
Primary Tumor
18%
Drug
18%
Adverse Event
18%
Ipilimumab
18%
Female Genital Tract Cancer
18%
Clinical Trial
15%
Neoplasm
11%
Survival
10%
Randomized Clinical Trial
7%
Progression Free Survival
7%
Monotherapy
6%
Biochemistry, Genetics and Molecular Biology
Overall Survival
26%
Survival
21%
Isocitrate Dehydrogenase
18%
Wild Type
12%
Adjustment
6%